BCT.TO Stock Forecast & Price Target
BCT.TO Stock
Price Forecast
The average stock forecast for
Briacell Therapeutics Corp (BCT.TO) in the next 12 months is 15.30 CAD. This price target corresponds to an upside
of
197.67%. The range of stock forecasts for BCT.TO is 15.15 - 15.75 CAD.
Based on the ratings of 5 analysts, the consensus recommendation for BCT.TO is
BUY.
| Target |
Low |
Average |
Median |
High |
| Price (CAD) |
15.15 |
15.30 |
15.30 |
15.75 |
| Upside |
194.75% |
197.67% |
197.67% |
206.42% |
Recommendation Trends
The latest consensus rating for BCT.TO is "BUY". This is the average
recommendation of 5 analysts: 0 strong sell,
0 sell, 1 hold, 3 buy, 1 strong buy. In the previous period, 5 analysts also majorly recommmended
"BUY" for BCT.TO.
BCT.TO Financial Stock
Forecast
Revenue This Year
from -M
Revenue Next Year
from -M